Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.45B.
ENTERPRISE VALUE (EV)
$1.45B
Rapport Therapeutics, Inc. Common Stock
Market Cap
$1.49B
Enterprise Value (EV)
$1.45B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Rapport Therapeutics, Inc. Common Stock (RAPP) | $1.49B | $1.45B |
| Phibro Animal Health Corporation (PAHC)vs › | $1.48B | $2.21B |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | $1.50B |
| Nutex Health, Inc. (NUTX)vs › | $1.50B | $1.65B |
| GH Research PLC (GHRS)vs › | $1.48B | $1.13B |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | $1.32B |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | $1.31B |
| Innoviva, Inc. (INVA)vs › | $1.54B | $1.24B |
| Certara, Inc. (CERT)vs › | $1.44B | $1.55B |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | $1.79B |
Market Cap
$1.49B
Total Debt
$8.73M
Cash
$52.65M
Enterprise Value
$1.45B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
